Resultados de procura - Zeinab Afify
- Mostrando 1 - 4 Resultados de 4
-
1
-
2
-
3
Pediatric relapsed/refractory ALK+ anaplastic large cell lymphoma treatment and outcomes in the targeted drug era por Lianna J. Marks, Victor Ritter, Jennifer E. Agrusa, Kala Y. Kamdar, Julie Rivers, Rebecca Gardner, Matthew J. Ehrhardt, Kaitlin J. Devine, Charles Phillips, Anne F. Reilly, Keith J. August, Joanna Weinstein, Prakash Satwani, Christopher J. Forlenza, Christine M. Smith, Chelsee Greer, Zeinab Afify, Carol Lin, Jennifer A. Belsky, Hilda Ding, David J. Hoogstra, Keri Toner, Michael P. Link, Liora M. Schultz, Eric Lowe, Catherine Aftandilian
Publicado 2025Artigo -
4
Outcomes of adults and children with primary mediastinal B‐cell lymphoma treated with dose‐adjusted <scp>EPOCH</scp>‐R por Lisa Giulino‐Roth, Tara J. O'Donohue, Zhengming Chen, Nancy L. Bartlett, Ann S. LaCasce, William Martin‐Doyle, Matthew J. Barth, Kimberly Davies, Kristie A. Blum, Beth Christian, Carla Casulo, Sonali M. Smith, James Godfrey, Amanda Termuhlen, Matthew J. Oberley, Sarah Alexander, Sheila Weitzman, Burton Appel, Benjamin Mizukawa, Jakub Svoboda, Zeinab Afify, Melinda Pauly, Hema Dave, Rebecca Gardner, Deborah M. Stephens, William Zeitler, Christopher J. Forlenza, Jennifer Levine, Michael E. Williams, J Sima, Catherine M. Bollard, John P. Leonard
Publicado 2017Artigo
Ferramentas de procura:
Materias Relacionadas
Internal medicine
Medicine
Retrospective cohort study
Cancer
Chemotherapy
Gastroenterology
Lymphoma
Oncology
Pediatrics
Physics
Surgery
ALK inhibitor
Anaplastic large-cell lymphoma
Anaplastic lymphoma kinase
Astrobiology
Astronomy
Atypical teratoid rhabdoid tumor
Biology
Biopsy
Brentuximab vedotin
CD30
Central nervous system
Chemotherapy regimen
Chromatin
Chromatin remodeling
Confidence interval
Crizotinib
Cyclophosphamide
Disease
Endoscopy